2025-02-012026-01-312026-01-31false13834732ADESHOLZ MEDICAL LTD2026-07-2886900falseiso4217:GBPxbrli:pure138347322025-01-31138347322026-01-31138347322025-02-012026-01-31138347322024-01-31138347322025-01-31138347322024-02-012025-01-3113834732bus:SmallEntities2025-02-012026-01-3113834732bus:AuditExempt-NoAccountantsReport2025-02-012026-01-3113834732bus:FullAccounts2025-02-012026-01-3113834732bus:PrivateLimitedCompanyLtd2025-02-012026-01-3113834732core:WithinOneYear2026-01-3113834732core:AfterOneYear2026-01-3113834732core:WithinOneYear2025-01-3113834732core:AfterOneYear2025-01-3113834732core:ShareCapital2026-01-3113834732core:SharePremium2026-01-3113834732core:RevaluationReserve2026-01-3113834732core:OtherReservesSubtotal2026-01-3113834732core:RetainedEarningsAccumulatedLosses2026-01-3113834732core:ShareCapital2025-01-3113834732core:SharePremium2025-01-3113834732core:RevaluationReserve2025-01-3113834732core:OtherReservesSubtotal2025-01-3113834732core:RetainedEarningsAccumulatedLosses2025-01-3113834732core:LandBuildings2026-01-3113834732core:PlantMachinery2026-01-3113834732core:Vehicles2026-01-3113834732core:FurnitureFittings2026-01-3113834732core:OfficeEquipment2026-01-3113834732core:NetGoodwill2026-01-3113834732core:IntangibleAssetsOtherThanGoodwill2026-01-3113834732core:ListedExchangeTraded2026-01-3113834732core:UnlistedNon-exchangeTraded2026-01-3113834732core:LandBuildings2025-01-3113834732core:PlantMachinery2025-01-3113834732core:Vehicles2025-01-3113834732core:FurnitureFittings2025-01-3113834732core:OfficeEquipment2025-01-3113834732core:NetGoodwill2025-01-3113834732core:IntangibleAssetsOtherThanGoodwill2025-01-3113834732core:ListedExchangeTraded2025-01-3113834732core:UnlistedNon-exchangeTraded2025-01-3113834732core:LandBuildings2025-02-012026-01-3113834732core:PlantMachinery2025-02-012026-01-3113834732core:Vehicles2025-02-012026-01-3113834732core:FurnitureFittings2025-02-012026-01-3113834732core:OfficeEquipment2025-02-012026-01-3113834732core:NetGoodwill2025-02-012026-01-3113834732core:IntangibleAssetsOtherThanGoodwill2025-02-012026-01-3113834732core:ListedExchangeTraded2025-02-012026-01-3113834732core:UnlistedNon-exchangeTraded2025-02-012026-01-3113834732core:MoreThanFiveYears2025-02-012026-01-3113834732core:Non-currentFinancialInstruments2026-01-3113834732core:Non-currentFinancialInstruments2025-01-3113834732dpl:CostSales2025-02-012026-01-3113834732dpl:DistributionCosts2025-02-012026-01-3113834732core:LandBuildings2025-02-012026-01-3113834732core:PlantMachinery2025-02-012026-01-3113834732core:Vehicles2025-02-012026-01-3113834732core:FurnitureFittings2025-02-012026-01-3113834732core:OfficeEquipment2025-02-012026-01-3113834732dpl:AdministrativeExpenses2025-02-012026-01-3113834732core:NetGoodwill2025-02-012026-01-3113834732core:IntangibleAssetsOtherThanGoodwill2025-02-012026-01-3113834732dpl:GroupUndertakings2025-02-012026-01-3113834732dpl:ParticipatingInterests2025-02-012026-01-3113834732dpl:GroupUndertakingscore:ListedExchangeTraded2025-02-012026-01-3113834732core:ListedExchangeTraded2025-02-012026-01-3113834732dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2025-02-012026-01-3113834732core:UnlistedNon-exchangeTraded2025-02-012026-01-3113834732dpl:CostSales2024-02-012025-01-3113834732dpl:DistributionCosts2024-02-012025-01-3113834732core:LandBuildings2024-02-012025-01-3113834732core:PlantMachinery2024-02-012025-01-3113834732core:Vehicles2024-02-012025-01-3113834732core:FurnitureFittings2024-02-012025-01-3113834732core:OfficeEquipment2024-02-012025-01-3113834732dpl:AdministrativeExpenses2024-02-012025-01-3113834732core:NetGoodwill2024-02-012025-01-3113834732core:IntangibleAssetsOtherThanGoodwill2024-02-012025-01-3113834732dpl:GroupUndertakings2024-02-012025-01-3113834732dpl:ParticipatingInterests2024-02-012025-01-3113834732dpl:GroupUndertakingscore:ListedExchangeTraded2024-02-012025-01-3113834732core:ListedExchangeTraded2024-02-012025-01-3113834732dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-02-012025-01-3113834732core:UnlistedNon-exchangeTraded2024-02-012025-01-3113834732core:NetGoodwill2026-01-3113834732core:IntangibleAssetsOtherThanGoodwill2026-01-3113834732core:LandBuildings2026-01-3113834732core:PlantMachinery2026-01-3113834732core:Vehicles2026-01-3113834732core:FurnitureFittings2026-01-3113834732core:OfficeEquipment2026-01-3113834732core:AfterOneYear2026-01-3113834732core:WithinOneYear2026-01-3113834732core:ListedExchangeTraded2026-01-3113834732core:UnlistedNon-exchangeTraded2026-01-3113834732core:ShareCapital2026-01-3113834732core:SharePremium2026-01-3113834732core:RevaluationReserve2026-01-3113834732core:OtherReservesSubtotal2026-01-3113834732core:RetainedEarningsAccumulatedLosses2026-01-3113834732core:NetGoodwill2025-01-3113834732core:IntangibleAssetsOtherThanGoodwill2025-01-3113834732core:LandBuildings2025-01-3113834732core:PlantMachinery2025-01-3113834732core:Vehicles2025-01-3113834732core:FurnitureFittings2025-01-3113834732core:OfficeEquipment2025-01-3113834732core:AfterOneYear2025-01-3113834732core:WithinOneYear2025-01-3113834732core:ListedExchangeTraded2025-01-3113834732core:UnlistedNon-exchangeTraded2025-01-3113834732core:ShareCapital2025-01-3113834732core:SharePremium2025-01-3113834732core:RevaluationReserve2025-01-3113834732core:OtherReservesSubtotal2025-01-3113834732core:RetainedEarningsAccumulatedLosses2025-01-3113834732core:NetGoodwill2024-01-3113834732core:IntangibleAssetsOtherThanGoodwill2024-01-3113834732core:LandBuildings2024-01-3113834732core:PlantMachinery2024-01-3113834732core:Vehicles2024-01-3113834732core:FurnitureFittings2024-01-3113834732core:OfficeEquipment2024-01-3113834732core:AfterOneYear2024-01-3113834732core:WithinOneYear2024-01-3113834732core:ListedExchangeTraded2024-01-3113834732core:UnlistedNon-exchangeTraded2024-01-3113834732core:ShareCapital2024-01-3113834732core:SharePremium2024-01-3113834732core:RevaluationReserve2024-01-3113834732core:OtherReservesSubtotal2024-01-3113834732core:RetainedEarningsAccumulatedLosses2024-01-3113834732core:AfterOneYear2025-02-012026-01-3113834732core:WithinOneYear2025-02-012026-01-3113834732core:Non-currentFinancialInstrumentscore:CostValuation2025-02-012026-01-3113834732core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-02-012026-01-3113834732core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-02-012026-01-3113834732core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-02-012026-01-3113834732core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-02-012026-01-3113834732core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-02-012026-01-3113834732core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-02-012026-01-3113834732core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-02-012026-01-3113834732core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-02-012026-01-3113834732core:Non-currentFinancialInstrumentscore:CostValuation2026-01-3113834732core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2026-01-3113834732core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2026-01-3113834732core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2026-01-3113834732core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2026-01-3113834732core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2026-01-3113834732core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2026-01-3113834732core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2026-01-3113834732core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2026-01-3113834732core:Non-currentFinancialInstrumentscore:CostValuation2025-01-3113834732core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-01-3113834732core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-01-3113834732core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-01-3113834732core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-01-3113834732core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-01-3113834732core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-01-3113834732core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-01-3113834732core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-01-3113834732bus:Director12025-02-012026-01-31

ADESHOLZ MEDICAL LTD

Registered Number
13834732
(England and Wales)

Unaudited Financial Statements for the Year ended
31 January 2026

ADESHOLZ MEDICAL LTD
Company Information
for the year from 1 February 2025 to 31 January 2026

Director

Adesola Olubukola Efunbajo

Registered Address

320 City Road
London
EC1V 2NZ

Registered Number

13834732 (England and Wales)
ADESHOLZ MEDICAL LTD
Balance Sheet as at
31 January 2026

Notes

2026

2025

£

£

£

£

Current assets
Cash at bank and on hand4,3352,608
4,3352,608
Creditors amounts falling due within one year3(1,514)(5,331)
Net current assets (liabilities)2,821(2,723)
Total assets less current liabilities2,821(2,723)
Net assets2,821(2,723)
Capital and reserves
Called up share capital11
Profit and loss account2,820(2,724)
Shareholders' funds2,821(2,723)
The financial statements were approved and authorised for issue by the Director on 28 July 2026, and are signed on its behalf by:
Adesola Olubukola Efunbajo
Director
Registered Company No. 13834732
ADESHOLZ MEDICAL LTD
Notes to the Financial Statements
for the year ended 31 January 2026

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Revenue from sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
2.Average number of employees

20262025
Average number of employees during the year11
3.Creditors: amounts due within one year

2026

2025

££
Taxation and social security1,514-
Other creditors-5,331
Total1,5145,331